Semaglutide Shows Potential to Improve Functional Recovery in Large Vessel Occlusion Stroke Patients Post-EVT
Glucagon-like Peptide 1 Receptor Agonist in Acute Large Vessel Occlusion Stroke Treated by Reperfusion Therapies
Abstract
Semaglutide, a GLP-1RA, indicated potential to improve 90-day functional recovery in large vessel occlusion stroke patients after endovascular thrombectomy.
TitrateLab articles covering Semaglutide
Written by TitrateLab, separately from the study summarized above.
